Larimar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	90.14	33.22	26.75	26.83	70.1	68.15
Short-Term Investments	85.3	150.24	60.04	91.6	-	24.49
Cash & Short-Term Investments	175.44	183.45	86.79	118.43	70.1	92.64
Cash Growth	-13.88%	111.38%	-26.71%	68.95%	-24.33%	9081.17%
Other Receivables	1	1.05	0.33	-	0.21	0.03
Receivables	1	1.05	0.33	-	0.21	0.03
Prepaid Expenses	6.79	10.8	3.05	2.31	1.9	5.28
Total Current Assets	183.22	195.3	90.18	120.74	72.2	97.95
Property, Plant & Equipment	2.98	3.72	3.76	3.69	4.46	4.98
Other Long-Term Assets	1.15	1.2	2	1.98	2.01	1.76
Total Assets	187.35	200.23	95.94	126.41	78.67	104.69
Accounts Payable	11.1	2.42	1.28	1.69	1.66	2.63
Accrued Expenses	32.87	20.87	7.39	8.41	6.59	5.84
Current Portion of Leases	1.15	1.06	0.84	0.61	0.59	0.52
Total Current Liabilities	45.12	24.36	9.51	10.71	8.85	8.99
Long-Term Leases	3.2	4.06	4.71	4.8	5.41	6
Total Liabilities	48.31	28.41	14.22	15.5	14.25	14.99
Common Stock	0.09	0.06	0.04	0.04	0.02	0.02
Additional Paid-In Capital	511.22	440.76	270.15	262.5	180.65	155.29
Retained Earnings	-372.33	-269.16	-188.55	-151.61	-116.25	-65.61
Comprehensive Income & Other	0.07	0.15	0.08	-0.03	-	0
Shareholders' Equity	139.04	171.81	81.72	110.9	64.41	89.69
Total Liabilities & Equity	187.35	200.23	95.94	126.41	78.67	104.69
Total Debt	4.35	5.12	5.55	5.41	6	6.52
Net Cash (Debt)	171.09	178.34	81.24	113.02	64.1	86.12
Net Cash Growth	-13.74%	119.51%	-28.12%	76.33%	-25.58%	9343.09%
Net Cash Per Share	2.53	2.91	1.85	4.39	3.73	7.25
Filing Date Shares Outstanding	85.59	64.03	63.8	43.27	17.71	15.37
Total Common Shares Outstanding	85.59	63.82	43.91	43.27	17.71	15.37
Working Capital	138.11	170.95	80.67	110.03	63.36	88.96
Book Value Per Share	1.62	2.69	1.86	2.56	3.64	5.84
Tangible Book Value	139.04	171.81	81.72	110.9	64.41	89.69
Tangible Book Value Per Share	1.62	2.69	1.86	2.56	3.64	5.84
Machinery	2.42	2.38	1.86	1.71	1.61	1.38
Leasehold Improvements	0.09	0.05	0.05	0.03	0.03	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q